ArticleScientific reports2017

Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors.

Yunching Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.